Features of post-endoscopic submucosal dissection electrocoagulation syndrome for early gastric neoplasm.
Early gastric neoplasm
Endoscopic submucosal dissection
Post-endoscopic submucosal dissection electrocoagulation syndrome
Journal
Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
revised:
01
06
2021
received:
07
03
2021
accepted:
13
06
2021
pubmed:
16
6
2021
medline:
3
3
2022
entrez:
15
6
2021
Statut:
ppublish
Résumé
Post-endoscopic submucosal dissection electrocoagulation syndrome (PECS) has become a common adverse event after colorectal endoscopic submucosal dissection (ESD) and esophageal ESD. However, little is known about PECS after gastric ESD. Therefore, this study aimed to investigate the clinical features of PECS after gastric ESD. Patients who underwent ESD for gastric cancer or adenoma between January 2016 and December 2017 were retrospectively investigated. PECS was clinically diagnosed based on the presence of upper abdominal pain and localized abdominal tenderness with a temperature of >37.5°C, without perforation. We analyzed the clinical features of PECS. A total of 637 ESD cases were enrolled; PECS occurred in 32 patients (5.0%), all of whom were diagnosed on postoperative Day 1. Among PECS cases, unplanned prolongation of hospitalization or fasting period was observed in 15 patients (47%). As a result, the median durations of hospitalization and fasting period were significantly longer in PECS cases (P = 0.008 and P < 0.001, respectively); however, the mean differences were less than a day. Additionally, all PECS cases recovered with conservative treatment. PECS is considered a common adverse event after gastric ESD. More than half of patients with PECS could start diets and be discharged as well as those without PECS.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
Post-endoscopic submucosal dissection electrocoagulation syndrome (PECS) has become a common adverse event after colorectal endoscopic submucosal dissection (ESD) and esophageal ESD. However, little is known about PECS after gastric ESD. Therefore, this study aimed to investigate the clinical features of PECS after gastric ESD.
METHODS
METHODS
Patients who underwent ESD for gastric cancer or adenoma between January 2016 and December 2017 were retrospectively investigated. PECS was clinically diagnosed based on the presence of upper abdominal pain and localized abdominal tenderness with a temperature of >37.5°C, without perforation. We analyzed the clinical features of PECS.
RESULTS
RESULTS
A total of 637 ESD cases were enrolled; PECS occurred in 32 patients (5.0%), all of whom were diagnosed on postoperative Day 1. Among PECS cases, unplanned prolongation of hospitalization or fasting period was observed in 15 patients (47%). As a result, the median durations of hospitalization and fasting period were significantly longer in PECS cases (P = 0.008 and P < 0.001, respectively); however, the mean differences were less than a day. Additionally, all PECS cases recovered with conservative treatment.
CONCLUSIONS
CONCLUSIONS
PECS is considered a common adverse event after gastric ESD. More than half of patients with PECS could start diets and be discharged as well as those without PECS.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3164-3169Informations de copyright
© 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Références
Isomoto H, Shikuwa S, Yamaguchi N et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut 2009; 58: 331-336.
Chung IK, Lee JH, Lee SH et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest. Endosc. 2009; 69: 1228-1235.
Gotoda T, Yamamoto H, Soetikno R. Endoscopic submucosal dissection of early gastric cancer. J. Gastroenterol. 2006; 41: 929-942.
Oka S, Tanaka S, Kaneko I et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest. Endosc. 2006; 64: 877-883.
Suzuki H, Takizawa K, Hirasawa T et al. Short-term outcomes of multicenter prospective cohort study of gastric endoscopic resection: ‘real-world evidence’ in Japan. Dig. Endosc. 2019; 31: 30-39.
Oda I, Suzuki H, Nonaka S, Yoshinaga S. Complications of gastric endoscopic submucosal dissection. Dig. Endosc. 2013; 25: 71-78.
Ono H, Yao K, Fujishiro M et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig. Endosc. 2016; 28: 3-15.
Jung D, Youn Y, Jahng J, Kim JH, Park H. Risk of electrocoagulation syndrome after endoscopic submucosal dissection in the colon and rectum. Endoscopy 2013; 45: 714-717.
Hong MJ, Kim JH, Lee SY, Sung IK, Park HS, Shim CS. Prevalence and clinical features of coagulation syndrome after endoscopic submucosal dissection for colorectal neoplasms. Dig. Dis. Sci. 2015; 60: 211-216.
Yamashina T, Takeuchi Y, Uedo N et al. Features of electrocoagulation syndrome after endoscopic submucosal dissection for colorectal neoplasm. J. Gastroenterol. Hepatol. 2016; 31: 615-620.
Ito S, Hotta K, Imai K et al. Risk factors of post-endoscopic submucosal dissection electrocoagulation syndrome for colorectal neoplasm. J. Gastroenterol. Hepatol. 2018; 33: 2001-2006.
Yamasaki Y, Takeuchi Y, Iwatsubo T et al. Line-assisted complete closure for a large mucosal defect after colorectal endoscopic submucosal dissection decreased post-electrocoagulation syndrome. Dig. Endosc. 2018; 30: 633-641.
Arimoto J, Higurashi T, Kato S et al. Risk factors for post-colorectal endoscopic submucosal dissection (ESD) coagulation syndrome: a multicenter, prospective, observational study. Endosc Int Open 2018; 6: E342-E349.
Kobayashi R, Hirasawa K, Sato C et al. Utility of multi-detector computed tomography scans after colorectal endoscopic submucosal dissection: a prospective study. Gastrointest. Endosc. 2018; 87: 818-826.
Zhang QS, Han B, Xu JH, Gao P, Shen YC. Clip closure of defect after endoscopic resection in patients with larger colorectal tumors decreased the adverse events. Gastrointest. Endosc. 2015; 82: 904-909.
Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. A randomized controlled trial of prophylactic antibiotics in the prevention of electrocoagulation syndrome after colorectal endoscopic submucosal dissection. Gastrointest. Endosc. 2017; 86: 349-357.
Nomura S, Shimura T, Katano T et al. A multicenter, single-blind randomized controlled trial of endoscopic clipping closure for preventing coagulation syndrome after colorectal endoscopic submucosal dissection. Gastrointest. Endosc. 2020; 91: 859-867.
Ma D, Youn Y, Jung D, Park J, Kim JH, Park H. Risk factors of electrocoagulation syndrome after esophageal endoscopic submucosal dissection. World J. Gastroenterol. 2018; 24: 1144-1151.
Yamaguchi H, Fukuzawa M, Kawai T et al. Predictive factors of postendoscopic submucosal dissection electrocoagulation syndrome and the utility of computed tomography scan after esophageal endoscopic submucosal dissection. Digestion 2020; 101: 579-589.
Sakai M, Sohda M, Saito H et al. Chest pain after endoscopic submucosal dissection for esophageal cancer: the simple and clinically useful surrogate marker for transmural thermal injury by electrocoagulation. Digestion 2020. https://doi.org/10.1159/000510353
Lee H, Cheoi K, Chung H et al. Clinical features and predictive factors of coagulation syndrome after endoscopic submucosal dissection for early gastric neoplasm. Gastric Cancer 2012; 15: 83-90.
Tanaka M, Ono H, Hasuike N, Takizawa K. Endoscopic submucosal dissection of early gastric cancer. Digestion 2008; 77: 23-28.
Draganov P, Gotoda T, Chavalitdhamrong D, Wallace M. Techniques of endoscopic submucosal dissection: application for the Western endoscopist? Gastrointest. Endosc. 2013; 78: 677-688.
Takizawa K, Oda I, Gotoda T et al. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection-an analysis of risk factors. Endoscopy 2008; 40: 179-183.
Berkley KJ. Sex differences in pain. Behav. Brain Sci. 1997; 20: 371-380.
Kim S, Cheoi K, Lee H et al. Safety and patient satisfaction of early diet after endoscopic submucosal dissection for gastric epithelial neoplasia: a prospective, randomized study. Surg. Endosc. 2014; 28: 1321-1329.
Oh KH, Lee SJ, Park JK. Optimal duration of fasting period after endoscopic submucosal dissection for gastric epithelial neoplasia: a prospective evaluation. J. Dig. Dis. 2017; 18: 445-452.
Itaba S, Iboshi Y, Nakamura K et al. Low-frequency of bacteremia after endoscopic submucosal dissection of the stomach. Dig. Endosc. 2011; 23: 69-72.
Liu Y, Chen Y, Shu X et al. Prophylactic antibiotics may be unnecessary in gastric endoscopic submucosal dissection due to the low incidence of bacteremia. Surg. Endosc. 2020; 34: 3788-3794.
Izumi K, Osada T, Sakamoto N et al. Frequent occurrence of fever in patients who have undergone endoscopic submucosal dissection for colorectal tumor, but bacteremia is not a significant cause. Surg. Endosc. 2014; 28: 2899-2904.
Kawata N, Tanaka M, Kakushima N et al. The low incidence of bacteremia after esophageal endoscopic submucosal dissection (ESD) obviates the need for prophylactic antibiotics in esophageal ESD. Surg. Endosc. 2016; 30: 5084-5090.